Tage Honore - 15 Mar 2023 Form 3 Insider Report for Vanda Pharmaceuticals Inc. (VNDA)

Role
Director
Signature
/s/ Tage Honore
Issuer symbol
VNDA
Transactions as of
15 Mar 2023
Net transactions value
$0
Form type
3
Filing time
17 Mar 2023, 16:49:33 UTC
Next filing
12 Jun 2023

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.